-- Anaesthesia as defined by the Food and drug administration (US) refers to reversible state of unconsciousness leading to lack of pain and muscle relaxation. The type of anaesthesia recommended by doctors depends on various parameters including health status of person, age, type of surgery and clinical tests results. Inhalation Anaesthesia is a novel method for providing anaesthesia to a patient via inhalation of some chemical compound. The main advantage of inhalation anaesthesia is that this technique offers a superior degree of control of aesthetic depth and rapid immediate recovery from anaesthesia these benefits has leveraged huge adoption of Inhalation Anaesthesia for providing general anaesthesia. The global inhalation anaesthesia market is expected to grow with the CAGR of over 3.5% during the forecast period of 2019-2026. Rising number of cosmetics surgeries have supplemented huge growth opportunity in the global inhalation anaesthesia market. As per International Society of Aesthetic Plastic Surgery (ISAPS) a total of 9.6 million cosmetic surgical procedures were performed globally in 2015 which hiked to 10.4 million in 2016 representing a year on year increase of over 8%. Further, growing geriatric population, escalating number of emergency cases and accident and reduction in the recovery time subsequently surgery with the use of inhalation anaesthesia coupled with the growing prevalence of chronic diseases are the other major factors driving the global inhalation anaesthesia market.
Get Sample (Free) @ http://www.briskinsights.com/sample-request/1682
ASIA PACIFIC: THE MOST LUCRATIVE REGION
Asia Pacific inhalation anaesthesia market is expected to grow at the highest rate over the forecast period of 2019-2026. The primary drivers for the high growth of Asia Pacific inhalation anaesthesia market are the rising prevalence of chronic diseases, increasing healthcare expenditure coupled with rising medical tourism and growing geriatric population. According to United Nations Economic and Social Commission for Asia and the Pacific (UN-ESCAP), Asia Pacific accounted for 60% (4.5billion) of the world’s total population as of 2016. By 2050, total number of people living within Asia Pacific will reach 5 billion. Further, Asia Pacific accounts for more than 60% (547million) of the world’s total geriatric population according to UN-ESCAP in 2016. By 2050, total geriatric population across Asia Pacific is anticipated to reach 1.3billion according to UN-ESCAP estimate. Aging population increases incidence probability of chronic & infectious diseases. High prevalence rate would drive demand for better healthcare management & treatment services driving demand for inhalation anaesthesia market for the forecasted period. Additionally, China spent 5.48% of its GDP on healthcare in 2014 which rose to 5.98% of the GDP in 2015, similarly net $104 billion was spent on healthcare in India in 2015 which rose to $110 billion in 2016 as per Indian brand equity foundation (IBEF) which is ~4.8% of the GDP aiding the inhalation anaesthesia market.
Get Sample (Free) @ http://www.briskinsights.com/sample-request/1682
ToC:
1. Preface
1.1. Report Scope and Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Segmentation
2. Executive Summary
............
3. Market Dynamics
3.1. Introduction
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Growing Geriatric Population
3.2.1.2. Increasing Prevalence of Chronic Diseases Globally
3.2.1.3. Escalating Number of Emergency Cases And Accident
3.2.1.4. Reduction in The Recovery Time Subsequently Surgery
3.2.2. Market Restraints
3.2.2.1. Side Effects Associated with Anaesthesia
3.2.2.2. Low Availability of Skilled Anesthetics Experts
3.2.3. Market Opportunities
3.2.3.1. Increasing Number of Cosmetic Surgeries
3.2.3.2. Growing Healthcare Expenditure
3.2.4. Market Challenges
3.2.4.1. Environmental Concerns Associated with Anaesthesia Gas
3.3. Attractive Investment Proposition, by Geography, 2018
3.4. Market share of Key Players, 2018
3.5. Top five findings and strategic analysis
4. Global Inhalation Anaesthesia Market, by Product
4.1. Overview
4.2. Desflurane
4.3. Sevoflurane
4.4. Isoflurane
5. Global Inhalation Anaesthesia Market, by Outlook
5.1. Overview
5.2. Induction Anaesthesia
5.3. Maintenance Anaesthesia
6. North America Inhalation Anaesthesia Market Analysis
6.1. Overview
6.1.1. North America Inhalation Anaesthesia Market, by Product, 2019-2026 (US$ Mn)
6.1.2. North America Inhalation Anaesthesia Market, by Outlook, 2019-2026 (US$ Mn)
6.1.3. North America Inhalation Anaesthesia Market, by Level of Automation, 2019-2026 (US$ Mn)
6.1.4. North America Inhalation Anaesthesia Market, by Country, 2019-2026 (US$ Mn)
6.1.4.1. United States
6.1.4.1.1. United States Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
6.1.4.2. Canada
6.1.4.2.1. Canada Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
7. Europe Inhalation Anaesthesia Market Analysis
7.1. Overview
7.1.1. Europe Inhalation Anaesthesia Market, by Product, 2019-2026 (US$ Mn)
7.1.2. Europe Inhalation Anaesthesia Market, by Outlook, 2019-2026 (US$ Mn)
7.1.3. Europe Inhalation Anaesthesia Market, by Level of Automation, 2019-2026 (US$ Mn)
7.1.4. Europe Inhalation Anaesthesia Market, by Country/Region, 2019-2026 (US$ Mn)
7.1.4.1. UK
7.1.4.1.1. UK Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
7.1.4.2. Germany
7.1.4.2.1. Germany Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
7.1.4.3. France
7.1.4.3.1. France Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
7.1.4.4. Rest of Europe
7.1.4.4.1. Rest of Europe Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
8. Asia Pacific Inhalation Anaesthesia Market Analysis
8.1. Overview
8.1.1. Asia Pacific Inhalation Anaesthesia Market, by Product, 2019-2026 (US$ Mn)
8.1.2. Asia Pacific Inhalation Anaesthesia Market, by Outlook, 2019-2026 (US$ Mn)
8.1.3. Asia Pacific Inhalation Anaesthesia Market, by Level of Automation, 2019-2026 (US$ Mn)
8.1.4. Asia Pacific Inhalation Anaesthesia Market, by Country/Region, 2019-2026 (US$ Mn)
8.1.4.1. China
8.1.4.1.1. China Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
8.1.4.2. India
8.1.4.2.1. India Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
8.1.4.3. Japan
8.1.4.3.1. Japan Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
8.1.4.4. Rest of Asia Pacific
8.1.4.4.1. Rest of Asia Pacific Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
9. Rest of the World Inhalation Anaesthesia Market Analysis
9.1. Overview
9.1.1. Rest of the World Inhalation Anaesthesia Market, by Product, 2019-2026 (US$ Mn)
9.1.2. Rest of the World Inhalation Anaesthesia Market, by Outlook, 2019-2026 (US$ Mn)
9.1.3. Rest of the World Inhalation Anaesthesia Market, by Level of Automation, 2019-2026 (US$ Mn)
9.1.4. Rest of the World Inhalation Anaesthesia Market, by Country/Region, 2019 – 2026 (US$ Mn)
9.1.4.1. Latin America
9.1.4.1.1. Latin America Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
9.1.4.2. MENA
9.1.4.2.1. MENA Inhalation Anaesthesia Market 2019 – 2026 (US$ Mn)
10. Company Profiles
10.2. Baxter Healthcare
10.3. Eisai Co., Ltd
10.4. Piramal Healthcare
10.5. Halocarbon Products
10.6. Hikma
10.7. Lunan Pharmaceuticals
10.8. Mylan Inc.
10.9. Richter Pharma
10.10. Par Pharmaceutical Companies.
..................................toc continued
To have a brief overview of the report please click on the following link: http://www.briskinsights.com/report/inhalation-anaesthesia-market
About Us:
Brisk Insights is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to aid businesses identify market opportunities optimize strategies.
Our team of 200 analysts’ provides enterprises with strategic insights. Brisk Insights works to help enterprises grow through strategic insights and actionable solutions
Contact Info:
Name: Jennifer Smith
Email: Send Email
Organization: Brisk Insights
Address: Office 1094, 109 Vernon House, Friar Lane, ,
Phone: +448081890034
Website: http://www.briskinsights.com
Release ID: 511085
Google
RSS